JP2022064912A5 - - Google Patents

Download PDF

Info

Publication number
JP2022064912A5
JP2022064912A5 JP2022005112A JP2022005112A JP2022064912A5 JP 2022064912 A5 JP2022064912 A5 JP 2022064912A5 JP 2022005112 A JP2022005112 A JP 2022005112A JP 2022005112 A JP2022005112 A JP 2022005112A JP 2022064912 A5 JP2022064912 A5 JP 2022064912A5
Authority
JP
Japan
Prior art keywords
protein
composition
salt
muscle
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022005112A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022064912A (ja
Filing date
Publication date
Priority claimed from PCT/US2016/067238 external-priority patent/WO2017106687A1/en
Application filed filed Critical
Publication of JP2022064912A publication Critical patent/JP2022064912A/ja
Publication of JP2022064912A5 publication Critical patent/JP2022064912A5/ja
Pending legal-status Critical Current

Links

JP2022005112A 2015-12-18 2022-01-17 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法 Pending JP2022064912A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562269573P 2015-12-18 2015-12-18
US62/269,573 2015-12-18
US201562273880P 2015-12-31 2015-12-31
US62/273,880 2015-12-31
PCT/US2016/067238 WO2017106687A1 (en) 2015-12-18 2016-12-16 Method and composition for increasing muscle protein synthesis and/or functional strength in mammals as well as method of producing a composition
JP2018532036A JP2018537987A (ja) 2015-12-18 2016-12-16 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018532036A Division JP2018537987A (ja) 2015-12-18 2016-12-16 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法

Publications (2)

Publication Number Publication Date
JP2022064912A JP2022064912A (ja) 2022-04-26
JP2022064912A5 true JP2022064912A5 (https=) 2022-08-31

Family

ID=57910110

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018532036A Withdrawn JP2018537987A (ja) 2015-12-18 2016-12-16 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法
JP2022005112A Pending JP2022064912A (ja) 2015-12-18 2022-01-17 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018532036A Withdrawn JP2018537987A (ja) 2015-12-18 2016-12-16 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法

Country Status (6)

Country Link
US (2) US10888571B2 (https=)
EP (1) EP3389385A1 (https=)
JP (2) JP2018537987A (https=)
BR (1) BR112018012410B1 (https=)
CA (1) CA3008033A1 (https=)
WO (1) WO2017106687A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018012410B1 (pt) * 2015-12-18 2022-12-20 Lonza Consumer Health Inc Composição para o aumento da síntese de proteína e/ou força funcional musculares em mamíferos
US11273138B2 (en) * 2017-11-02 2022-03-15 Bioventures, Llc Use of amino acid supplementation for improved muscle protein synthesis
US11785966B2 (en) * 2019-03-06 2023-10-17 Anipha Technologies Pty Ltd Use of gamma-quaternary ammonium butyrate compound in preparation of an animal feed additive
CA3153328A1 (en) * 2019-10-16 2021-04-22 Aouatef Bellamine Method and composition for increasing muscle protein synthesis
CA3153332A1 (en) * 2019-10-16 2021-04-22 Aouatef Bellamine Method and composition for increasing muscle protein synthesis
DE102022114966A1 (de) 2022-06-14 2023-12-14 Alzchem Trostberg Gmbh Wasserlösliches Kreatin-Agglomerat

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687782A (en) 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
US4883672A (en) 1988-04-29 1989-11-28 Shug Austin L Method for preventing diet induced carnitine deficiency in domesticated dogs and cats
WO1998000148A1 (de) * 1996-06-28 1998-01-08 Ipr-Institute For Pharmaceutical Research Ag Arzneimittelzubereitungen, enthaltend kreatin mit mindestens einem salz von calcium, magnesium, mangan oder zink
US6232346B1 (en) * 1997-03-27 2001-05-15 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
IT1291127B1 (it) 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US6159942A (en) 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
IT1306173B1 (it) 1999-07-23 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
JP2003529347A (ja) 2000-01-25 2003-10-07 ジュヴェノン インコーポレイテッド 高齢ペット用の栄養補給食品
US20030138547A1 (en) 2002-01-22 2003-07-24 Mars, Incorporated Weight management system for animals
DK1830883T3 (da) 2004-12-29 2013-11-25 Hills Pet Nutrition Inc Fremgangsmåde til at hæmme en nedgang i indlæring og/eller hukommelse hos dyr
US7645742B2 (en) * 2005-06-22 2010-01-12 Advocare International, L.P. Composition for enhancing cellular energy
US20080085343A1 (en) * 2006-09-14 2008-04-10 Petty Holly T Novel Low Allergenic Food Bar
WO2008115563A1 (en) * 2007-03-19 2008-09-25 University Of Florida Research Foundation, Inc. Liquid nutrient composition for improving performance
US7790688B2 (en) * 2008-01-11 2010-09-07 Healthspan Solutions, Llc Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
US8426395B2 (en) 2008-05-30 2013-04-23 Northern Northern Innovations Holding Corp Preparations containing creatine and imino sugars
FR2938733A1 (fr) 2008-11-21 2010-05-28 Holymark Composition administrable par voie orale,en particulier pour personne pratiquant une activite physique et complement alimentaire renfermant une telle composition
US8784844B2 (en) 2009-09-30 2014-07-22 Lonza Ltd. Arabinogalactan for enhancing the adaptive immune response
MX2013013098A (es) 2011-05-10 2013-12-16 Nestec Sa Metodos y composiciones para fomentar el crecimiento de la masa corporal magra.
ITTO20121098A1 (it) 2012-12-18 2014-06-19 Univ Degli Studi Genova Procedimento per sintetizzare derivati della creatina
WO2015094772A1 (en) 2013-12-18 2015-06-25 Abbott Laboratories Methods for increasing skeletal muscle protein synthesis using green tea extract
CA2951567C (en) 2014-06-12 2023-10-31 Lonza, Inc. Method for decreasing skeletal muscle damage and/or oxidative stress in mammals
BR112018012410B1 (pt) * 2015-12-18 2022-12-20 Lonza Consumer Health Inc Composição para o aumento da síntese de proteína e/ou força funcional musculares em mamíferos

Similar Documents

Publication Publication Date Title
JP2022064912A5 (https=)
JP5227021B2 (ja) 飼料添加剤としてのグアニジノ酢酸
EP1210940A2 (en) Antifatigue composition
JP5911806B2 (ja) カルニチン顆粒およびその製造方法
JP2016516040A5 (https=)
JP2018537987A5 (https=)
US9238024B2 (en) Methods for improving health in canines
JP2024122087A (ja) 遊離アミノ酸吸収促進剤及び遊離アミノ酸の吸収を促進する方法
JP2022064912A (ja) 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法
CN108308493A (zh) 一种含虾青素的抗疲劳固体饮料及制备方法
JP6441825B2 (ja) フィラーの効能維持用組成物
JP4928473B2 (ja) グアニジノ酢酸の塩、付加化合物及び錯化合物
JPH0331211A (ja) 腎不全のための栄養組成物
JP2002065212A (ja) 筋強化用食品組成物及び筋強化剤
SK115399A3 (en) Process for the preparation of stable, non-hygroscopic salts of l(-)carnitine and alkanoyl l(-)carnitines
MXPA02001550A (es) Suplemento dietetico que mejora el metabolismo de la energia muscular y que comprende una alcanoil carnitina y ribosa.
PT1355540E (pt) Suplemento alimentar com efeito de emagrecimento
JP5689458B2 (ja) グルコサミンを包含する栄養補助食品を安定化させる方法
RS52129B (sr) Dijetetski dodatak koji obezbeđuje energiju skeletnim mišićima i štiti kardiovaskularni trakt
JP2002338473A (ja) 抗疲労組成物
JP4873778B2 (ja) 抗疲労剤
JP7069531B2 (ja) ピロロキノリンキノン又はその塩と分岐鎖アミノ酸とを含むカプセル
JP7167287B2 (ja) 圧縮成型製剤
JP2021536494A (ja) マグネシウム含有製剤及びその使用
JP7781309B2 (ja) ウイルス感染後疲労症候群治療に用いるためのクレアチンを含む組成物